NCT00382070-D2
Dataset Information
Dataset ID: NCT00382070-D2
PubMed ID (PMID):
Publication Title:
Use of letrozole after aromatase inhibitor-based therapy (NRG Oncology/NSABP B-42): a randomized, double-blind, placebo-controlled phase 3 trial. Supplementary appendix
Description of Dataset:
There are two data submissions (NCT00382070-D1 and NCT00382070-D2) for PMID 30509771, the primary publication for NCT00382070 (NSABP-B-42). This dataset, NCT00382070-D2, contains toxicity data.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT00382070 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®